Ofatumumab-associated acute respiratory manifestations: clinical characteristics and treatment

被引：7

作者：

Bonanni, Alice ^{[1
]}

Bertelli, Enrica ^{[1
]}

Moscatelli, Andrea ^{[2
]}

Lampugnani, Elisabetta ^{[2
]}

Bodria, Monica ^{[1
]}

Ravani, Pietro ^{[3
]}

Ghiggeri, Gian Marco ^{[1
]}

机构：

[1] Giannina Gaslini Childrens Hosp, Div Nephrol, Dialysis, Transplantat, Via Gerolamo Gaslini 5, I-16148 Genoa, Italy

[2] Giannina Gaslini Childrens Hosp, Dept Crit Care & Perinatal Med, Neonatal & Pediat ICU, I-16148 Genoa, Italy

[3] Univ Calgary, Div Nephrol, Calgary, AB T2N 2T9, Canada

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2016年 / 82卷 / 04期

关键词：

ANTIBODY; TRIAL;

D O I：

10.1111/bcp.13029

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1146 / 1148

页数：3

共 7 条

[1] Ofatumumab for Rituximab- Resistant Nephrotic Syndrome
Basu, Biswanath
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13) : 1268 - 1270
[2] Regulatory T cells and minimal change nephropathy: in the midst of a complex network
Bertelli, R.
Bonanni, A.
Di Donato, A.
Cioni, M.
Ravani, P.
Ghiggeri, G. M.
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 183 (02) : 166 - 174
[3] Bonanni Alice, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-210208
[4] Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20
Du, Jiamu
Yang, Hui
Guo, Yajun
Ding, Jianping
[J]. MOLECULAR IMMUNOLOGY, 2009, 46 (11-12) : 2419 - 2423
[5] Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma - a phase II trial
Furtado, Michelle
Dyer, Martin J. S.
Johnson, Rod
Berrow, Margie
Rule, Simon
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (04) : 575 - 578
[6] Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis A phase 2 study
Sorensen, Per S.
Lisby, Steen
Grove, Richard
Derosier, Frederick
Shackelford, Steve
Havrdova, Eva
Drulovic, Jelena
Filippi, Massimo
[J]. NEUROLOGY, 2014, 82 (07) : 573 - 581
[7] Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial
Taylor, Peter C.
Quattrocchi, Emilia
Mallett, Stephen
Kurrasch, Regina
Petersen, Jorgen
Chang, David J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (12) : 2119 - 2125

← 1 →